{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "7614953", "DateCompleted": {"Year": "1995", "Month": "08", "Day": "24"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0091-6765", "JournalIssue": {"Volume": "103 Suppl 2", "Issue": "Suppl 2", "PubDate": {"Year": "1995", "Month": "Mar"}}, "Title": "Environmental health perspectives", "ISOAbbreviation": "Environ Health Perspect"}, "ArticleTitle": "Airway epithelial cell responses to ozone injury.", "Pagination": {"StartPage": "91", "EndPage": "95", "MedlinePgn": "91-5"}, "Abstract": {"AbstractText": ["The airway epithelial cells is an important target in ozone injury. Once activated, the airway epithelium responds in three phases. The initial, or immediate phase, involves activation of constitutive cells, often through direct covalent interactions including the formation of secondary ozonolysis products--hydroxyhydroperoxides, aldehydes, and hydrogen peroxide. Recently, we found hydroxyhydroperoxides to be potent agonists of bioactive eicosanoid formation by human airway epithelial cells in culture. Other probable immediate events include activation and inactivation of enzymes present on the epithelial surface (e.g., neutral endopeptidase). During the next 2 to 24 hr, or early phase, epithelial cells respond by synthesis and release of chemotactic factors, including chemokines--macrophage inflammatory protein-2, RANTES, and interleukin-8. Infiltrating leukocytes during this period also release elastase, an important agonist of epithelial cell mucus secretion and additional chemokine formation. The third (late) phase of ozone injury is characterized by eosinophil or monocyte infiltration. Cytokine expression leads to alteration of structural protein synthesis, with increases in fibronectin evident by in situ hybridization. Synthesis of epithelial antiproteases, e.g., secretory leukocyte protease inhibitor, may also increase locally 24 to 48 hr after elastase concentrations become excessive. Thus, the epithelium is not merely a passive barrier to ozone injury but has a dynamic role in directing the migration, activating, and then counteracting inflammatory cells. Through these complex interactions, epithelial cells can be viewed as the initiators (alpha) and the receptors (omega) of ozone-induced airway disease."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental Health, University of Cincinnati 45267-0056, USA."}], "Identifier": [], "LastName": "Leikauf", "ForeName": "G D", "Initials": "GD"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Simpson", "ForeName": "L G", "Initials": "LG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Santrock", "ForeName": "J", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhao", "ForeName": "Q", "Initials": "Q"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Abbinante-Nissen", "ForeName": "J", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhou", "ForeName": "S", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Driscoll", "ForeName": "K E", "Initials": "KE"}], "GrantList": [{"GrantID": "P30-ES06096", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01-ES06562", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01-ES06677", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, U.S. Gov't, P.H.S.", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Environ Health Perspect", "NlmUniqueID": "0330411", "ISSNLinking": "0091-6765"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Bronchi"}, {"QualifierName": ["drug effects"], "DescriptorName": "Epithelium"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": ["drug effects"], "DescriptorName": "Trachea"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Chem Res Toxicol. 1992 Jan-Feb;5(1):134-41", "ArticleIdList": ["1581530"]}, {"Citation": "Am J Respir Cell Mol Biol. 1992 May;6(5):481-97", "ArticleIdList": ["1581072"]}, {"Citation": "Fundam Appl Toxicol. 1992 Feb;18(2):175-80", "ArticleIdList": ["1601217"]}, {"Citation": "Toxicol Appl Pharmacol. 1993 Apr;119(2):306-9", "ArticleIdList": ["8480341"]}, {"Citation": "Am J Physiol. 1993 Sep;265(3 Pt 1):L286-92", "ArticleIdList": ["8105697"]}, {"Citation": "Am J Respir Cell Mol Biol. 1993 Dec;9(6):594-602", "ArticleIdList": ["8257591"]}, {"Citation": "Atmos Environ. 1969 Nov;3(6):669-82", "ArticleIdList": ["5382204"]}, {"Citation": "Arch Environ Health. 1971 Aug;23(2):142-8", "ArticleIdList": ["5558147"]}, {"Citation": "Chem Phys Lipids. 1974 May;12(3):153-71", "ArticleIdList": ["4858129"]}, {"Citation": "J Biochem. 1976 Jun;79(6):1253-61", "ArticleIdList": ["821941"]}, {"Citation": "Arch Biochem Biophys. 1979 Oct 1;197(1):264-72", "ArticleIdList": ["575611"]}, {"Citation": "Arch Biochem Biophys. 1981 Apr 15;208(1):212-20", "ArticleIdList": ["7259179"]}, {"Citation": "Biochem Biophys Res Commun. 1981 Sep 30;102(2):640-5", "ArticleIdList": ["6975626"]}, {"Citation": "Arch Biochem Biophys. 1982 Jun;216(1):34-41", "ArticleIdList": ["7103513"]}, {"Citation": "Arch Biochem Biophys. 1984 Feb 15;229(1):259-69", "ArticleIdList": ["6703696"]}, {"Citation": "Toxicol Appl Pharmacol. 1985 Jun 15;79(1):11-27", "ArticleIdList": ["3840292"]}, {"Citation": "Biochem Biophys Res Commun. 1985 Dec 17;133(2):773-9", "ArticleIdList": ["4084297"]}, {"Citation": "J Appl Physiol (1985). 1986 Apr;60(4):1321-6", "ArticleIdList": ["3084448"]}, {"Citation": "Am Rev Respir Dis. 1986 Sep;134(3):572-9", "ArticleIdList": ["3530074"]}, {"Citation": "Environ Res. 1987 Apr;42(2):406-14", "ArticleIdList": ["3106026"]}, {"Citation": "J Appl Physiol (1985). 1987 Sep;63(3):996-1002", "ArticleIdList": ["3654479"]}, {"Citation": "Am Rev Respir Dis. 1988 Feb;137(2):435-42", "ArticleIdList": ["3341632"]}, {"Citation": "JAPCA. 1988 Jan;38(1):28-35", "ArticleIdList": ["3356996"]}, {"Citation": "Exp Lung Res. 1988;14(2):225-45", "ArticleIdList": ["3371276"]}, {"Citation": "Am Rev Respir Dis. 1989 Feb;139(2):407-15", "ArticleIdList": ["2913889"]}, {"Citation": "Environ Res. 1978 Aug;17(1):84-101", "ArticleIdList": ["318509"]}, {"Citation": "J Clin Invest. 1990 Mar;85(3):682-9", "ArticleIdList": ["2107207"]}, {"Citation": "Am Rev Respir Dis. 1990 Nov;142(5):1158-63", "ArticleIdList": ["2240838"]}, {"Citation": "Am J Respir Cell Mol Biol. 1991 Jan;4(1):72-81", "ArticleIdList": ["1846079"]}, {"Citation": "Free Radic Biol Med. 1990;9(3):245-65", "ArticleIdList": ["2272533"]}, {"Citation": "Am J Respir Cell Mol Biol. 1991 Mar;4(3):255-63", "ArticleIdList": ["1705810"]}, {"Citation": "Development. 1991 Jan;111(1):117-30", "ArticleIdList": ["2015789"]}, {"Citation": "Am J Physiol. 1991 Jun;260(6 Pt 1):L530-8", "ArticleIdList": ["1647680"]}, {"Citation": "J Immunol. 1991 Aug 1;147(3):972-9", "ArticleIdList": ["1861084"]}, {"Citation": "Am J Respir Cell Mol Biol. 1991 Aug;5(2):155-62", "ArticleIdList": ["1892646"]}, {"Citation": "Chem Res Toxicol. 1991 May-Jun;4(3):341-8", "ArticleIdList": ["1912318"]}, {"Citation": "Am Rev Respir Dis. 1991 Nov;144(5):1187-98", "ArticleIdList": ["1659270"]}, {"Citation": "J Immunol. 1991 Dec 15;147(12):4293-301", "ArticleIdList": ["1753099"]}, {"Citation": "Free Radic Biol Med. 1992;12(1):83-8", "ArticleIdList": ["1537573"]}, {"Citation": "Toxicol Appl Pharmacol. 1992 Mar;113(1):13-8", "ArticleIdList": ["1553746"]}, {"Citation": "J Appl Physiol (1985). 1992 Feb;72(2):670-6", "ArticleIdList": ["1559947"]}, {"Citation": "Arch Environ Health. 1992 Mar-Apr;47(2):107-15", "ArticleIdList": ["1567233"]}, {"Citation": "Arch Environ Health. 1992 Mar-Apr;47(2):116-22", "ArticleIdList": ["1567234"]}, {"Citation": "Pulm Pharmacol. 1990;3(4):180-4", "ArticleIdList": ["2135222"]}, {"Citation": "J Clin Invest. 1992 May;89(5):1478-84", "ArticleIdList": ["1569186"]}, {"Citation": "Pulm Pharmacol. 1992;5(1):39-50", "ArticleIdList": ["1375522"]}]}], "History": [{"Year": "1995", "Month": "3", "Day": "1"}, {"Year": "1995", "Month": "3", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1995", "Month": "3", "Day": "1", "Hour": "0", "Minute": "0"}, {"Year": "1995", "Month": "3", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["7614953", "PMC1518831", "10.1289/ehp.95103s291"]}}], "PubmedBookArticle": []}